Defects in ankyrin-based membrane protein targeting pathways underlie atrial fibrillation

Circulation

Volumn 124, Issue 11, 2011, Pages 1212-1222

  Cunha, Shane R ^a,d   Hund, Thomas J ^a,c   Hashemi, Seyed ^e   Voigt, Niels ^f   Li, Na ^g   Wright, Patrick ^a   Koval, Olha ^e   Li, Jingdong ^a   Gudmundsson, Hjalti ^e   Gumina, Richard J ^a,b   Karck, Matthias ^f   Schott, Jean Jacques ^h   Probst, Vincent ^h   Le Marec, Herve ^h   Anderson, Mark E ^e   Dobrev, Dobromir ^f   Wehrens, Xander H T ^g   Mohler, Peter J ^a,b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b Division of Cardiovascular Medicine   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h UNIVERSITÉ DE NANTES   (France)

Author keywords

Arrhythmia (mechanisms); cytoskeleton; ion channel; protein trafficking

Indexed keywords

ANKYRIN; CALCIUM CHANNEL L TYPE; VOLTAGE GATED CALCIUM CHANNEL;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; LOSS OF FUNCTION MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING;

ADULT; AGED; AMINO ACID SEQUENCE; ANIMALS; ANKYRINS; ATRIAL FIBRILLATION; CALCIUM CHANNELS; CHILD; FEMALE; HUMANS; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYOCYTES, CARDIAC; PROTEIN TRANSPORT; RATS; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 80052755777     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.023986     Document Type: Article

References (36)

1. Damani SB, Topol EJ. Molecular genetics of atrial fibrillation. Genome Med. 2009;1:54.
2. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Sudy). Am J Cardiol. 1994;74:236-241. (Pubitemid 24239044)
3. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-988.
4. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119-125. (Pubitemid 44420743)
5. Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol. 2008;1: 62-73.
6. Ellinor PT, Petrov-Kondratov VI, Zakharova E, Nam EG, MacRae CA. Potassium channel gene mutations rarely cause atrial fibrillation. BMC Med Genet. 2006;7:70.
7. Cunha SR, Mohler PJ. Ankyrin protein networks in membrane formation and stabilization. J Cell Mol Med. 2009;3:4364-4376.
8. Kline CF, Kurata HT, Hund TJ, Cunha SR, Koval OM, Wright PJ, Christensen M, Anderson ME, Nichols CG, Mohler PJ. Dual role of KATP channel C-terminal motif in membrane targeting and metabolic regulation. Proc Natl Acad Sci USA. 2009;106:16669-16674.
9. Mohler PJ, Schott JJ, Gramolini AO, Dilly KW, Guatimosim S, duBell WH, Song LS, Haurogne K, Kyndt F, Ali ME, Rogers TB, Lederer WJ, Escande D, Le Marec H, Bennett V. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature. 2003;421: 634-639. (Pubitemid 36227671)
10. Scotland P, Zhou D, Benveniste H, Bennett V. Nervous system defects of ankyrinB (-/-) mice suggest functional overlap between the cell adhesion molecule l1 and 440-kd ankyrinB in premyelinated axons. J Cell Biol. 1998;143:1305-1315. (Pubitemid 28559831)
11. Mohler PJ, Davis JQ, Bennett V. Ankyrin-B coordinates the Na/K ATPase, Na/Ca exchanger, and InsP(3) receptor in a cardiac T-tubule/SR microdomain. PLoS Biol. 2005;3:e423.
12. Le Scouarnec S, Bhasin N, Vieyres C, Hund TJ, Cunha SR, Koval O, Marionneau C, Chen B, Wu Y, Demolombe S, Song LS, Le Marec H, Probst V, Schott JJ, Anderson ME, Mohler PJ. Dysfunction in ankyrin-B-dependent ion channel and transporter targeting causes human sinus node disease. Proc Natl Acad Sci USA. 2008;105:15617-15622.
13. Mohler PJ, Splawski I, Napolitano C, Bottelli G, Sharpe L, Timothy K, Priori SG, Keating MT, Bennett V. A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. Proc Natl Acad Sci USA. 2004; 101:9137-9142. (Pubitemid 38781624)
14. Mohler PJ, Le Scouarnec S, Denjoy I, Lowe JS, Guicheney P, Caron L, Driskell IM, Schott JJ, Norris K, Leenhardt A, Kim RB, Escande D, Roden DM. Defining the cellular phenotype of "ankyrin-B syndrome" variants: human Ank2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes. Circulation. 2007; 115:432-441. (Pubitemid 46184194)
15. Chelu MG, Sarma S, Sood S, Wang S, van Oort RJ, Skapura DG, Li N, Santonastasi M, Muller FU, Schmitz W, Schotten U, Anderson ME, Valderrabano M, Dobrev D, Wehrens XH. Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice. J Clin Invest. 2009;119:1940-1951.
16. Mangoni ME, Couette B, Bourinet E, Platzer J, Reimer D, Striessnig J, Nargeot J. Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity. Proc Natl Acad Sci USA. 2003;100:5543-5548. (Pubitemid 36542741)
17. Dobrev D, Graf E, Wettwer E, Himmel HM, Hala O, Doerfel C, Christ T, Schuler S, Ravens U. Molecular basis of downregulation of G-proteincoupled inward rectifying K(+) current (I(K,ACh) in chronic human atrial fibrillation: decrease in GIRK4 mRNA correlates with reduced I(K,ACh) and muscarinic receptor-mediated shortening of action potentials. Circulation. 2001;104:2551-2557. (Pubitemid 33104792)
18. Cunha SR, Bhasin N, Mohler PJ. Targeting and stability of Na/Ca exchanger 1 in cardiomyocytes requires direct interaction with the membrane adaptor ankyrin-B. J Biol Chem. 2007;282:4875-4883. (Pubitemid 47100976)
19. Lowe JS, Palygin O, Bhasin N, Hund TJ, Boyden PA, Shibata E, Anderson ME, Mohler PJ. Voltage-gated Nav channel targeting in the heart requires an ankyrin-G dependent cellular pathway. J Cell Biol. 2008;180:173-186.
20. Garrido JJ, Giraud P, Carlier E, Fernandes F, Moussif A, Fache MP, Debanne D, Dargent B. A targeting motif involved in sodium channel clustering at the axonal initial segment. Science. 2003;300:2091-2094. (Pubitemid 36760135)
21. Mohler PJ, Rivolta I, Napolitano C, Lemaillet G, Lambert S, Priori SG, Bennett V. Nav1.5 e1053k mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes. Proc Natl Acad Sci USA. 2004;101:17533-17538. (Pubitemid 39657438)
22. Mohler PJ, Healy JA, Xue H, Puca AA, Kline CF, Rand Allingham R, Kranias EG, Rockman HA, Bennett V. Ankyrin-B syndrome: enhanced cardiac function balanced by risk of cardiac death and premature senescence. PLoS ONE. 2007;2:e1051.
23. Courtemanche M, Ramirez RJ, Nattel S. Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model. Am J Physiol. 1998;275:H301-H321.
24. Bhasin N, Cunha SR, Mudannayake M, Gigena MS, Rogers TB, Mohler PJ. Molecular basis for PP2A regulatory subunit B56{alpha} targeting in cardiomyocytes. Am J Physiol. 2007;293:H109-H119. (Pubitemid 47105065)
25. Cunha SR, Mohler PJ. Obscurin targets ankyrin-B and protein phosphatase 2a to the cardiac M-line. J Biol Chem. 2008;283:31968-31980.
26. Mohler PJ, Bennett V. Defects in ankyrin-based cellular pathways in metazoan physiology. Front Biosci. 2005;10:2832-2840. (Pubitemid 40905277)
27. Yue L, Feng J, Gaspo R, Li GR, Wang Z, Nattel S. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res. 1997;81:512-525. (Pubitemid 27432738)
28. Christ T, Boknik P, Wohrl S, Wettwer E, Graf EM, Bosch RF, Knaut M, Schmitz W, Ravens U, Dobrev D. L-type Ca2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation. 2004;110:2651-2657. (Pubitemid 39453015)
29. Gaborit N, Steenman M, Lamirault G, Le Meur N, Le Bouter S, Lande G, Leger J, Charpentier F, Christ T, Dobrev D, Escande D, Nattel S, Demolombe S. Human atrial ion channel and transporter subunit geneexpression remodeling associated with valvular heart disease and atrial fibrillation. Circulation. 2005;112:471-481. (Pubitemid 41060786)
30. Antzelevitch C, Pollevick GD, Cordeiro JM, Casis O, Sanguinetti MC, Aizawa Y, Guerchicoff A, Pfeiffer R, Oliva A, Wollnik B, Gelber P, Bonaros EP Jr, Burashnikov E, Wu Y, Sargent JD, Schickel S, Oberheiden R, Bhatia A, Hsu LF, Haissaguerre M, Schimpf R, Borggrefe M, Wolpert C. Loss-offunction mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation. 2007;115:442-449. (Pubitemid 46184195)
31. Zhang Z, He Y, Tuteja D, Xu D, Timofeyev V, Zhang Q, Glatter KA, Xu Y, Shin HS, Low R, Chiamvimonvat N. Functional roles of Cav1.3(alpha1d) calcium channels in atria: insights gained from genetargeted null mutant mice. Circulation. 2005;112:1936-1944. (Pubitemid 41377411)
32. Mancarella S, Yue Y, Karnabi E, Qu Y, El-Sherif N, Boutjdir M. Impaired Ca2+ homeostasis is associated with atrial fibrillation in the alpha1d L-type Ca2+ channel KO mouse. Am J Physiol. 2008;295:H2017-H2024.
33. Obermair GJ, Schlick B, Di Biase V, Subramanyam P, Gebhart M, Baumgartner S, Flucher BE. Reciprocal interactions regulate targeting of calcium channel beta subunits and membrane expression of alpha1 subunits in cultured hippocampal neurons. J Biol Chem. 2010;285: 5776-5791.
34. Wang HG, George MS, Kim J, Wang C, Pitt GS. Ca2+/calmodulin regulates trafficking of Ca(v)1.2 Ca2+ channels in cultured hippocampal neurons. J Neurosci. 2007;27:9086-9093. (Pubitemid 47312052)
35. Sadeghi A, Doyle AD, Johnson BD. Regulation of the cardiac L-type Ca2+ channel by the actin-binding proteins alpha-actinin and dystrophin. Am J Physiol. 2002;282:C1502-C1511. (Pubitemid 34663099)
36. Altier C, Dubel SJ, Barrere C, Jarvis SE, Stotz SC, Spaetgens RL, Scott JD, Cornet V, De Waard M, Zamponi GW, Nargeot J, Bourinet E. Trafficking of L-type calcium channels mediated by the postsynaptic scaffolding protein akap79. J Biol Chem. 2002;277: 33598-33603.